Last Updated: October 1, 2026

Details for Patent: 12,653,779


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 12,653,779 protect, and when does it expire?

Patent 12,653,779 protects VIZZ and is included in one NDA.

This patent has eighty-two patent family members in twenty-two countries.


Drugs Protected by US Patent 12,653,779

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Lenz Therap VIZZ aceclidine hydrochloride SOLUTION/DROPS;OPHTHALMIC 218585-001 Jul 31, 2025 RX Yes Yes ⤷  Start Trial ⤷  Start Trial TREATMENT OF PRESBYOPIA ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 12,653,779

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2014311558 ⤷  Start Trial
Australia 2016280615 ⤷  Start Trial
Australia 2016280616 ⤷  Start Trial
Australia 2019200623 ⤷  Start Trial
Brazil 112017025722 ⤷  Start Trial
Brazil 112017025726 ⤷  Start Trial
Canada 2922802 ⤷  Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.